These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 7157894

  • 21. [Side effects of oral contraceptives from a dermatological viewpoint].
    Marghescu S.
    Ther Ggw; 1979 Aug 17; 118(8):1230-43. PubMed ID: 158843
    [No Abstract] [Full Text] [Related]

  • 22. [Porphyria cutanea tarda following treatment with depot estrogens in patients with prostate cancer].
    Linss G, Schmechel C.
    Z Urol Nephrol; 1990 May 17; 83(5):229-31. PubMed ID: 2392882
    [Abstract] [Full Text] [Related]

  • 23. Hereditary uroporphyrinogen-decarboxylase deficiency predisposing porphyria cutanea tarda (chronic hepatic porphyria) in females after oral contraceptive medication.
    Sixel-Dietrich F, Doss M.
    Arch Dermatol Res; 1985 May 17; 278(1):13-6. PubMed ID: 4096525
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Rifampicin-induced porphyria cutanea tarda.
    Millar JW.
    Br J Dis Chest; 1980 Oct 17; 74(4):405-8. PubMed ID: 6452153
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [The effect of exposure to silicon dioxide on the occurrence of porphyria tarda].
    Hykes P, Kordac V, Havránková E.
    Sb Lek; 1989 Sep 17; 91(8-9):249-52. PubMed ID: 2562772
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Aspects of primary liver cancer and its relation to porphyria cutanea tarda and porphyria acuta intermittens.
    Hardell L.
    IARC Sci Publ; 1986 Sep 17; (77):591-2. PubMed ID: 3596757
    [No Abstract] [Full Text] [Related]

  • 33. [Cutaneous effects in hormonal contraception].
    Thomas P, Dalle E, Revillon B, Delecour M, Devarenne-nicolle MF, Pagniez I.
    NPN Med; 1985 Jan 01; 5(81):19-24. PubMed ID: 12281276
    [Abstract] [Full Text] [Related]

  • 34. Porphyria cutanea tarda symptomatica.
    Handa F, Walia RL, Sadana JK, Gill BS.
    Indian J Dermatol; 1985 Apr 01; 30(2):49-51. PubMed ID: 3843234
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Porphyria cutanea tarda induced by oral contraceptive].
    Horkay I, Tamási P, Prékopa A, Dalmy L, Dán S.
    Orv Hetil; 1973 Dec 16; 114(50):3026-8. PubMed ID: 4769423
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Porphyria cutanea and oral contraceptives].
    Le Reun M, Deschamps P.
    Concours Med; 1974 Apr 27; 96(17):2697, 2699-700, 2703-4. PubMed ID: 4469488
    [No Abstract] [Full Text] [Related]

  • 39. [Coexistence of psoriasis vulgaris and porphyria cutanea tarda in a patient treated with hydroxycarbamid. Case report].
    Zaumseil RP, Taube KM.
    Dermatol Monatsschr; 1986 Apr 27; 172(3):159-62. PubMed ID: 3699211
    [No Abstract] [Full Text] [Related]

  • 40. [Contraception with Monogest in young women].
    Chalupa M.
    Cesk Gynekol; 1981 May 27; 46(4):300-1. PubMed ID: 7249099
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.